UnitedHealth Group (NYSE:UNH) shares climbed 2.3% following the healthcare company’s reaffirmation of its 2025 earnings outlook ahead of scheduled investor meetings this week.
In an SEC filing, the company noted that senior executives will meet with investors and analysts between September 8-10 to review their financial guidance, confirming the adjusted earnings-per-share expectations initially announced on July 29.
UnitedHealth emphasized that its forecast incorporates the acquisition of Amedisys, completed in August 2025. The company anticipates this transaction will be “modestly dilutive” to adjusted earnings per share due to financing expenses and integration costs.
The meetings may also cover UnitedHealth’s broader strategy, market positioning, and previously released results, according to the filing.
The positive response in the stock suggests that investors welcomed the reaffirmation, signaling confidence in the company’s ability to meet its 2025 earnings targets despite the short-term effects of the Amedisys acquisition.
UnitedHealth Group stock price
This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.